Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q6SD
|
||||
Former ID |
DCL000859
|
||||
Drug Name |
Lamectacin
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] | Discontinued in Phase 3 | [547323] | ||
Company |
AstraZeneca & NewBiotics
|
||||
Structure |
Download2D MOL |
||||
Formula |
C26H19Cl3N2O6S2
|
||||
Canonical SMILES |
C1C(=C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CS3)C(=O)O)COC4=C(C=C<br />C(=C4)Cl)OC5=C(C=C(C=C5)Cl)Cl
|
||||
InChI |
1S/C26H19Cl3N2O6S2/c27-14-3-5-18(17(29)8-14)37-19-6-4-15(28)9-20(19)36-11-13-12-39-25-22(24(33)31(25)23(13)26(34)35)30-21(32)10-16-2-1-7-38-16/h1-9,22,25H,10-12H2,(H,30,32)(H,34,35)/t22-,25-/m1/s1
|
||||
InChIKey |
XKYWDADJBIQZBT-RCZVLFRGSA-N
|
||||
CAS Number |
CAS 371914-92-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
ChEBI ID |
ChEBI:8707
|
||||
SuperDrug ATC ID |
N05AH04
|
||||
SuperDrug CAS ID |
cas=111974697
|
||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Antagonist | [536295], [536773] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.